Reviewed by Peptide Treatments Medical Advisory Board (Medical Advisory Board)

Fox04-DRI: Bloodwork Guide

Name: Fox04-DRI Bloodwork Guide — What to Monitor
Published: 2026-03-12

Recommended lab tests and biomarkers to monitor before, during, and after Fox04-DRI therapy. Testing schedules are based on clinical protocols and published monitoring guidelines.

Back to Fox04-DRI overview

During Treatment (2 tests)

Biomarker	Expected Effect	Retest
p16INK4a	↓ decreases	Every 12 weeks
SA-beta-gal	↓ decreases	Every 12 weeks